A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus
about
DNA gyrase, topoisomerase IV, and the 4-quinolonesCloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutationsMultiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus.Clonal diversity of Chilean isolates of enterohemorrhagic Escherichia coli from patients with hemolytic-uremic syndrome, asymptomatic subjects, animal reservoirs, and food products.Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporterMutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.Effects of mutations in GrlA of topoisomerase IV from Staphylococcus aureus on quinolone and coumarin activity.Detection of novel mutations in the gyrA gene of Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis and direct DNA sequencing.Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis.Antimicrobial susceptibility of coagulase-negative staphylococci.Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin.Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin.Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesisMechanisms and frequency of resistance to premafloxacin in Staphylococcus aureus: novel mutations suggest novel drug-target interactionsMechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus.Novelties in the field of anti-infective compounds in 1999.Bactericidal activities of BMS-284756, a novel Des-F(6)-quinolone, against Staphylococcus aureus strains with topoisomerase mutations.Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone.DX-619, a novel des-fluoro(6) quinolone manifesting low frequency of selection of resistant Staphylococcus aureus mutants: quinolone resistance beyond modification of type II topoisomerases.Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureusThe Vibrio cholerae genome contains two unique circular chromosomes.A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens.Topoisomerase targeting with and resistance to gemifloxacin in Staphylococcus aureusActivity of and resistance to moxifloxacin in Staphylococcus aureus.Hospital-acquired infections: diseases with increasingly limited therapies.Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolonesInducible NorA-mediated multidrug resistance in Staphylococcus aureus.Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin.Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus.Altering gene expression by aminocoumarins: the role of DNA supercoiling in Staphylococcus aureus.Scanning the landscape of genome architecture of non-O1 and non-O139 Vibrio cholerae by whole genome mapping reveals extensive population genetic diversityEfflux-mediated fluoroquinolone resistance in Staphylococcus aureus.In vivo selection during pefloxacin therapy of a mutant of Staphylococcus aureus with two mechanisms of fluoroquinolone resistance.Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection modelDetection of gyrA gene mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: analysis by polymerase chain reaction and automated direct DNA sequencing.Sequential acquisition of norfloxacin and ofloxacin resistance by methicillin-resistant and -susceptible Staphylococcus aureus
P2860
Q24643546-D575F89E-DA80-4ACC-A811-67DFEB69E8E1Q28369291-07656F1C-4403-426E-9B6B-011E6F3B947CQ30784091-CD7FCD84-A9F1-46FD-BA58-FB778A367226Q31050150-260B7942-7594-4241-9A57-A38D0DD42512Q33505192-266A4919-B924-422B-82E5-0A26ECEB3857Q33555822-ABF1EB31-C264-4FCB-926A-52E1B1D5827DQ33690598-2D4F12BC-F126-4AFF-8E34-68DEFD157F14Q33698247-E8408AD6-6AE0-4741-9A19-496C753C578EQ33750373-8DA865C0-B234-48FF-859C-23C33D3C2B99Q33758823-4C1FEA44-C335-42D3-8ABF-40A621CB7A90Q33760227-FE98C9A6-C9A7-4313-B27E-11E3F0C2A945Q33770013-5AECA048-3A96-409D-B9AC-6D872ABEF187Q33979593-5B13A5B1-969F-4AEB-AB65-562286EB704AQ33980255-59AB053C-E3A4-409B-83B9-C6181CE4DF81Q33980991-675F1E40-AF3E-450F-A969-AD77DC6B6AD5Q33983092-859E779B-2CF6-4CB1-BE4C-EDFAFBAB5548Q34092340-0764061A-C5D5-4E16-881E-A64F1EE97D2AQ34104362-A6938C91-0539-4A64-A1BE-6E52A592381AQ34142238-30818D71-DBE0-48DD-9DEE-540B2237CA49Q34228402-A84F9655-2EBB-44A9-88D1-EFA4BC9F99F3Q34352135-1632374A-423C-4A76-B0C6-1202D6E6F7CCQ34352260-F2045DF8-E227-4EED-AC43-EEE5B8D232B4Q34481163-F709B1DC-ECC4-4A95-A93E-F5FEC6537CF2Q34642972-C87DE9B0-3B1F-4A98-8003-9412F602FD28Q34725095-2B877F93-B9F2-46BD-8EF3-544B5711F8EFQ34885313-F9F682BF-8F0E-47E2-AFC3-7504BC53A506Q35113057-0CA63D81-810F-434A-986A-0B5517AAB4DDQ35115756-F697AE5E-0F27-43BE-8C68-8197CDFACF93Q35120701-8781F34A-6FE5-4E6F-A187-E106CE1EC652Q35126142-AF8F0AFE-FFF2-449D-9CEC-1A27C5263529Q35135636-13F55846-2971-4542-A50F-14C4396ADF77Q35138781-0DAF01D4-80BD-41AB-80AA-0A943F4AD464Q35148453-DF64C929-8AC2-486A-929A-75C9CFB3765EQ35202681-D9C9C410-DFA0-4815-B05F-7AC732055FE3Q35814875-074FF0AA-CC23-4870-94DA-00CD78731A91Q35820858-AA3F1D92-8EEC-453C-A6DC-A50E11C5C52AQ35821659-E28B0146-1BE0-4B0F-A09A-93A4D9D789E1Q35822889-4023F623-B75D-49EA-9B4E-B9EC2AD0F792Q35837021-B382F824-904E-4898-801C-B5642A614853Q35899647-31A58C8E-23F6-4614-8F91-E41E4A1129F2
P2860
A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus
@ast
A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus
@en
type
label
A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus
@ast
A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus
@en
prefLabel
A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus
@ast
A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus
@en
P2093
P2860
P1476
A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus
@en
P2093
D C Hooper
J S Wolfson
M Trucksis
P2860
P304
P356
10.1128/JB.173.18.5854-5860.1991
P407
P577
1991-09-01T00:00:00Z